Nonclinical precedent Request an invite

Padcev: what safety margin did regulators accept?

enfortumab vedotin · Nectin-4
Safety margin at NOAEL
Monkey ~3-fold and rat (MTD) ~2-fold human systemic exposure at recommended dose
“The systematic exposure to AGS-22M6E in cynomolgus monkeys was ~3-fold the human systemic exposure at the recommended clinical dose. In rats, at the maximum tolerated dose (MTD), the systematic exposure was also ~2-fold the human systemic exposure at the recommended clinical dose.”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗
NOAEL / key findings
Monkey HNSTD/MTD 3 mg/kg, rat MTD 5 mg/kg; skin, injection site, bone marrow, liver, eye, male reproductive organs
“In the 4-week monkey study (# 20005664), AGS-22M6E systemic exposure at 3 mg/kg (MTD/HNSTD) was 2450 µg.hr/mL (Day 1) and 903 µg.hr/mL (Day 22).”
✓ VerifiedFDA multi-discipline review, p. 56Source ↗

Same question, other ADCs

Adcetris

brentuximab vedotin · CD30
Monkey NOAEL serum exposure ~2 to 3x human exposure at the clinical dose

Besponsa

inotuzumab ozogamicin · CD22
No NOAEL for rat male reproductive effects, seen at ~0.3x human AUC

Datroway

datopotamab deruxtecan · Trop-2
Monkey NOAEL 10 mg/kg (lung, cornea, skin, liver, thymus): margin of exposure 0.25 (below human exposure)

Decnupaz

pivekimab sunirine · CD123
No NOAEL in 13-week monkey study: thymic atrophy at the lowest dose (0.01 mg/kg)

Elahere

mirvetuximab soravtansine · FRα
Monkey NOAEL 4 mg/kg: AUC margin 0.09 (AUC0-24 vs AUCtau) to 0.57 (AUC0-∞)

Enhertu

fam-trastuzumab deruxtecan · HER2
Monkey 30 mg/kg (3-month study) ≥7x human AUC at 5.4 mg/kg

Kadcyla

ado-trastuzumab emtansine · HER2
Monkey HNSTD 10 mg/kg (2040 µg DM1/m2) approximately equivalent to the clinical dose

Tivdak

tisotumab vedotin · Tissue factor
Monkey HNSTD 3 mg/kg ~1.35-2.56x human exposure (Cmax and AUC)

Trodelvy

sacituzumab govitecan · Trop-2
Monkey NOAEL/HNSTD 50 mg/kg: 6.4x (total antibody), 4.6x (total SN-38), 3.1x (free SN-38) human exposure at 10 mg/kg

Zynlonta

loncastuximab tesirine · CD19
Monkey 0.3 mg/kg ~3x human AUC at MRHD 0.15 mg/kg

Emrelis

telisotuzumab vedotin · c-Met
Not stated in public reviews

Mylotarg

gemtuzumab ozogamicin · CD33
Not stated in public reviews

Polivy

polatuzumab vedotin · CD79b
Not stated in public reviews

Summary across all 14 ADCs →